The Familial Tasmanian Haematological Malignancies Study (FaTHMS) : Its origins, its history and the phenomenon of anticipation

Transfusion and Apheresis Science

Volumn 49, Issue 2, 2013, Pages 113-115

  Lowenthal, Ray M ^a   Tegg, Elizabeth M ^b   Dickinson, Joanne L ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ANTICIPATION; ARTICLE; AUSTRALIA; CHRONIC LEUKEMIA; EXTENDED FAMILY; FAMILIAL DISEASE; FAMILY HISTORY; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT TRANSFORMATION; MULTIPLE MYELOMA; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA;

AGE FACTORS; CASE-CONTROL STUDIES; FAMILY; HEMATOLOGIC NEOPLASMS; HUMANS; TASMANIA;

EID: 84886640346     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.07.011     Document Type: Article

References (30)

1. Clements F.W., Gibson H.B., Howeler-Coy J.E. Goitre studies in Tasmania. 16 years' prophylaxis with iodine. Bull World Health Organization 1968, 38:197-318.
2. Shepherd J.J. The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized?. Arch Surg 1991, 126:935-952.
3. Sack J., Healey D.L., de Graaf A.P., et al. The problem of overlapping glaucoma families in the glaucoma inheritance study in Tasmania (GIST). Ophthalmic Genet 1996, 17:209-214.
4. Giles G., Lickiss J.N., Panton J., Baikie M.J., Lowenthal R.M. Lymphoma in Tasmania and service in the armed forces. Med J Aust 1980, 2(6):339-340. [letter].
5. Lickiss J.N., Giles G.G., Baikie M.J., Lowenthal R.M., Challis D., Panton J. Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-80: patterns in space and time. J Natl Cancer Inst 1984, 72:1223-1231.
6. Macdonald D., Cross N.C. Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy. Pathobiology 2007, 74:81-88.
7. Quaglino D., Hayhoe F.G. Observations on the periodic acid-Schiff reaction in lymphoproliferative diseases. J Pathol Bacteriol 1959, 78:521-532.
8. Lickiss J.N., Baikie A.G., Panton J. Lymphoproliferative and myeloproliferative disease in Tasmania. Natl Cancer Inst Monogr 1977, 47:37-39.
9. Baikie A.G., Kinlen L.J., Pike M.C. Detection and assessment of case clustering in Burkitt's lymphoma and Hodgkin's disease. Recent Results Cancer Res 1972, 39:201-209.
10. Giles G.G., Lickiss J.N., Baikie M.J., Lowenthal R.M., Panton J. Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-80: occupational and familial aspects. J Natl Cancer Inst 1984, 72:1233-1240.
11. Tegg E.M., Thomson R.J., Stankovich J.M., et al. Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes. Br J Haematol 2010, 150:456-462.
12. Grosbois B., Jego P., Attal M., et al. Familial multiple myeloma: report of fifteen families. Br J Haematol 1999, 105:768-770.
13. Goldin L.R., Bjorkholm M., Kristinsson S.Y., Turesson I., Landgren O. Highly increased familial risks for specific lymphoma subtypes. Br J Haematol 2009, 146:91-94.
14. Goldin L.R., Kristinsson S.Y., Liang X.S., Derolf A.R., Landgren O., Bjorkholm M. Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol 2012, 30:179-183.
15. Yuille M.R., Matutes E., Marossy A., Hilditch B., Catovsky D., Houlston R.S. Familial chronic lymphocytic leukaemia: a survey and review of published studies. Br J Haematol 2000, 109:794-799.
16. Jonsson V., Tjonnfjord G.E., Johannesen T.B., Ly B., Olsen J.H., Yuille M. Familial chronic lymphocytic leukemia in Norway and Denmark. Comments on pleiotropy and birth order. In Vivo 2010, 24:85-95.
17. Houlston R.S., Catovsky D., Yuille M.R. Genetic susceptibility to chronic lymphocytic leukemia. Leukemia 2002, 16:1008-1014.
18. Lowenthal R.M., Panton J.B., Baikie M.J., Lickiss J.N. Exposure to high tension power lines and childhood leukaemia: a pilot study. Med J Aust 1991, 155(5):347. [letter].
19. Lowenthal R.M., Tuck D.M., Bray I.C. Residential exposure to electric power transmission lines and risk of lymphoproliferative and myeloproliferative disorders: a case-control study. Int Med J 2007, 37:614-619.
20. Kheifets L., Ahlbom A., Crespi C.M., et al. Pooled analysis of recent studies on magnetic fields and childhood leukaemia. Br J Cancer 2010, 103:1128-1135.
21. Lin R., Charlesworth J., van der Mei I., Taylor B.V. The genetics of multiple sclerosis. Pract Neurol 2012, 12:279-288.
22. FitzGerald L.M., Patterson B., Thomson R., et al. Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease. Eur J Hum Genet 2009, 17:368-377.
23. Stefansdottir V., Johannsson O.T., Skirton H., Tryggvadottir L., Tulinius H., Jonsson J.J. The use of genealogy databases for risk assessment in genetic health service: a systematic review. J Community Genet 2012.
24. Friedman J.E. Anticipation in hereditary disease: the history of a biomedical concept. Hum Genet 2011, 130:705-714.
25. Marelli C., Cazeneuve C., Brice A., Stevanin G., Durr A. Autosomal dominant cerebellar ataxias. Rev Neurol (Paris) 2011, 167:385-400.
26. Bozzao C., Lastella P., Ponz de Leon M., et al. Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome. Cancer 2011, 117:4325-4335.
27. Bozzao C., Lastella P., Stella A. Anticipation in Lynch syndrome: where we are where we go. Curr Genomics 2011, 12:451-465.
28. Martin J.J. Spinocerebellar ataxia type 7. Handb Clin Neurol 2012, 103:475-491.
29. Marrone A., Walne A., Dokal I. Dyskeratosis congenita: telomerase, telomeres and anticipation. Curr Opin Genet Dev 2005, 15:249-257.
30. Tegg E.M., Thomson R.J., Stankovich J.M., et al. Anticipation in familial hematologic malignancies. Blood 2011, 117:1308-1310.